[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
ONLINE FIRST
June 6, 2012

Inhaled Hypertonic Saline in Infants and Young Children With Cystic Fibrosis

Author Affiliations

Author Affiliations: Case Western Reserve University School of Medicine and Rainbow Babies and Children's Hospital, Cleveland, Ohio (Drs Dasenbrook and Konstan).

JAMA. 2012;307(21):2316-2317. doi:10.1001/jama.2012.5853

In the past 70 years, survival of patients with cystic fibrosis (CF) has improved substantially.1 However, median predicted survival is only 38 years of age.2 Extending life expectancy to that of healthy individuals would presumably require initiating treatment in early infancy before the onset of irreversible lung damage. The recent advent of universal newborn screening for CF provides this opportunity.

First Page Preview View Large
First page PDF preview
First page PDF preview
×